Abstract：
OBJECTIVE: To systematically evaluate the decision effectiveness of patient decision aids (PtDAs) on the decision-making effect of patients with advanced chronic kidney disease.
METHODS: Two authors independently searched ten electronic databases [Web of science, PubMed, the Cochrane Library, Embase, CINAHL, EBSCO, CBM, CNKI, WanFang DATA and Vip database], to include randomized controlled trials of interventions through PtDAs in patients with advanced chronic kidney disease published from the inception of the database until April 2024. Two authors conducted a comprehensive quality evaluation (Cochrane 5.1.0) before independently extracting and analyzing the data with RevMan 5.2.
RESULTS: The study included 11 randomized controlled trials with a total of 1613 patients. According to the results, PtDAs can improve the decision knowledge [SMD = 0.53, 95% CI (0.26, 0.80), P = 0.0002] and decision preparation [SMD = 2.34, 95% CI (2.04, 2.65), P < 0.00001] of patients with advanced chronic kidney disease. Additionally, there was a substantial decrease in the levels of decision regret [SMD = - 1.33, 95% CI (- 2.11, - 0.55), P < 0.05] and decision conflict [SMD = - 0.88, 95% CI (- 1.47, - 0.28), P = 0.004].
CONCLUSIONS: The current available evidence indicates that PtDAs can significantly enhance the decision knowledge and decision preparation of patients with advanced chronic kidney disease. Additionally, PtDAs can reduce the levels of decision regret and decision conflict.
BACKGROUND: CRD42023433798.
METHODS: Two authors independently searched ten electronic databases [Web of science, PubMed, the Cochrane Library, Embase, CINAHL, EBSCO, CBM, CNKI, WanFang DATA and Vip database], to include randomized controlled trials of interventions through PtDAs in patients with advanced chronic kidney disease published from the inception of the database until April 2024. Two authors conducted a comprehensive quality evaluation (Cochrane 5.1.0) before independently extracting and analyzing the data with RevMan 5.2.
RESULTS: The study included 11 randomized controlled trials with a total of 1613 patients. According to the results, PtDAs can improve the decision knowledge [SMD = 0.53, 95% CI (0.26, 0.80), P = 0.0002] and decision preparation [SMD = 2.34, 95% CI (2.04, 2.65), P < 0.00001] of patients with advanced chronic kidney disease. Additionally, there was a substantial decrease in the levels of decision regret [SMD = - 1.33, 95% CI (- 2.11, - 0.55), P < 0.05] and decision conflict [SMD = - 0.88, 95% CI (- 1.47, - 0.28), P = 0.004].
CONCLUSIONS: The current available evidence indicates that PtDAs can significantly enhance the decision knowledge and decision preparation of patients with advanced chronic kidney disease. Additionally, PtDAs can reduce the levels of decision regret and decision conflict.
BACKGROUND: CRD42023433798.
摘要：
目的：系统评价患者决策辅助（PtDA）对晚期慢性肾脏病患者决策效果的决策效能。
方法：两位作者独立搜索了十个电子数据库[Webofscience，PubMed,Cochrane图书馆,Embase,CINAHL,EBSCO,CBM,CNKI,万方数据和Vip数据库]，纳入从数据库开始到2024年4月发表的通过PtDA对晚期慢性肾脏病患者进行干预的随机对照试验.两位作者在使用RevMan5.2独立提取和分析数据之前，进行了综合质量评估（Cochrane5.1.0）。
结果：该研究包括11项随机对照试验，共1613例患者。根据结果,PTDA可以提高决策知识[SMD=0.53，95%CI(0.26，0.80)，P=0.0002]和决策准备[SMD=2.34，95%CI（2.04，2.65），慢性肾脏病晚期患者P<0.00001。此外,决策遗憾水平大幅下降[SMD=-1.33，95%CI(-2.11，-0.55)，P<0.05和决策冲突[SMD=-0.88，95%CI(-1.47，-0.28)，P=0.004]。
结论：现有证据表明，PtDA可显著增强晚期慢性肾脏病患者的决策知识和决策准备。此外,PtDA可以减少决策遗憾和决策冲突的级别。
背景：CRD42023433798.
方法：两位作者独立搜索了十个电子数据库[Webofscience，PubMed,Cochrane图书馆,Embase,CINAHL,EBSCO,CBM,CNKI,万方数据和Vip数据库]，纳入从数据库开始到2024年4月发表的通过PtDA对晚期慢性肾脏病患者进行干预的随机对照试验.两位作者在使用RevMan5.2独立提取和分析数据之前，进行了综合质量评估（Cochrane5.1.0）。
结果：该研究包括11项随机对照试验，共1613例患者。根据结果,PTDA可以提高决策知识[SMD=0.53，95%CI(0.26，0.80)，P=0.0002]和决策准备[SMD=2.34，95%CI（2.04，2.65），慢性肾脏病晚期患者P<0.00001。此外,决策遗憾水平大幅下降[SMD=-1.33，95%CI(-2.11，-0.55)，P<0.05和决策冲突[SMD=-0.88，95%CI(-1.47，-0.28)，P=0.004]。
结论：现有证据表明，PtDA可显著增强晚期慢性肾脏病患者的决策知识和决策准备。此外,PtDA可以减少决策遗憾和决策冲突的级别。
背景：CRD42023433798.
